TOP TIERMARKET NEWSWIRE

News & sentiment

REZOLUTE INC (RZLT) — News & AI sentiment

REZOLUTE INC (RZLT) news roundup. 20 stories aggregated over the last 30 days. Average 30-day sentiment is 59.7/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →

24h stories

0

7d stories

0

30d stories

20

avg sentiment 59.7/100

Insider net (90d)

$0

0 buys · 0 sells

Congress (90d)

0

0 buys · 0 sells

RZLT news in the last 24 hours, 7 days, 30 days and 90 days

How much RZLT coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time window	RZLT stories	Avg AI sentiment	Read
Last 24 hours	0	—	no coverage
Last 7 days	0	—	no coverage
Last 30 days	20	59.7/100	RZLT headlines →
Last 90 days	36	54.9/100	RZLT headlines →

Latest stories on RZLT

Rezolute stock holds Buy rating at H.C. Wainwright on trial progress

Investing.com Analyst Ratings61 · neutralanalyst

Oct 15

Citizens reiterates Market Outperform on Rezolute stock on trial data

Investing.com Analyst Ratings63 · neutralanalyst

Oct 15

Rezolute, Inc. (RZLT) files 8-K

SEC 8-K50 · neutralgeneral

Oct 14

Rezolute completes enrollment in upLIFT study of ersodetug

The Fly58 · neutralproduct/pr

Oct 14

Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

GlobeNewswire56 · neutralproduct/pr

Oct 14

Rezolute Announces Completion of Enrollment in Phase 3 upLIFT Study of Ersodetug in Tumor Hyperinsulinism

Business Insider56 · neutralproduct/pr

Oct 14

Rezolute upgraded at Cantor on pre-BLA meeting for ersodetug

Seeking Alpha67 · bullishanalyst

Oct 6

Rezolute price target raised to $12 from $9 at Lake Street

The Fly63 · neutralanalyst

Oct 6

Citizens raises Rezolute stock price target on FDA feedback

Investing.com Analyst Ratings61 · neutralanalyst

Oct 6

Rezolute price target raised to $15 from $11 at Citizens

The Fly61 · neutralanalyst

Oct 6

Rezolute upgraded to Overweight from Neutral at Cantor Fitzgerald

The Fly61 · neutralanalyst

Oct 5

Rezolute Gets FDA Nod For Pre-BLA Meeting Despite Phase 3 Miss — Retail Expects ‘Huge Rerating’

Stocktwits News58 · neutralgeneral

Oct 5

Rezolute, Inc. (RZLT) files 8-K

SEC 8-K50 · neutralgeneral

Oct 5

Rezolute announces FDA recommendation to hold pre-BLA meeting for ersodetug

The Fly59 · neutralgeneral

Oct 5

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

Business Insider63 · neutralproduct/pr

Oct 5

Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism

GlobeNewswire63 · neutralproduct/pr

Oct 5

Rezolute initiated with a Buy at Lake Street

The Fly61 · neutralanalyst

Sep 30

Rezolute stock rating upgraded to Buy at Craig-Hallum on trial data

Investing.com Analyst Ratings61 · neutralanalyst

Sep 29

Craig-Hallum upgraded Rezolute to Buy ahead of study data

The Fly61 · neutralanalyst

Sep 29

Rezolute upgraded to Buy from Hold at Craig-Hallum

The Fly61 · neutralanalyst

Sep 29

Rezolute price target raised to $10 from $6 at Jones

The Fly61 · neutralanalyst

Sep 28

H.C. Wainwright raises Rezolute stock price target on trial data

Investing.com Analyst Ratings61 · neutralanalyst

Sep 28

Rezolute price target raised to $10 from $5 at H.C. Wainwright

The Fly63 · neutralanalyst

Sep 25

Citizens reiterates Rezolute stock rating on tumor trial results due

Investing.com Analyst Ratings56 · neutralanalyst

Sep 25

Rezolute reports Q4 EPS (20c), consensus (14c)

The Fly53 · neutralearnings

Sep 24

Open RZLT in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →